LifeVantage Corporation logo
LifeVantage Corporation LFVN
$ 6.16 1.82%

Quarterly report 2025-Q3
added 11-04-2025

report update icon

LifeVantage Corporation Balance Sheet 2011-2026 | LFVN

Annual Balance Sheet LifeVantage Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-8.52 M -3.27 M -8.52 M -4.44 M -4.99 M - -17.4 M -11.2 M -4.02 M 1.53 M 6.87 M 9.39 M -26.3 M -24.6 M -5.94 M

Long Term Debt

9.81 M 11.8 M 11.6 M 13.2 M 16 M - - 3.41 M 5.44 M 7.41 M 9.63 M 25.1 M - - -

Long Term Debt Current

1.87 M 1.81 M 1.52 M 2.6 M 2.15 M - 1.45 M 2 M 2 M 2 M 11.1 M 4.7 M - - -

Total Non Current Liabilities

- - - - - - 1.88 M 5.39 M 7.37 M 9.58 M 11.7 M 27.3 M 973 K 217 K 19.9 M

Total Current Liabilities

27.2 M 22.3 M 19.6 M 25.7 M 25.2 M 25 M 26.2 M 23.8 M 23.4 M 28.6 M 25.9 M 22.7 M 20.6 M 16 M -

Total Liabilities

37.3 M 34.3 M 31.5 M 39.2 M 41.9 M 25.6 M 28.1 M 29.2 M 30.7 M 38.1 M 37.6 M 50 M 21.5 M 16.2 M 33.3 M

Deferred Revenue

711 K 860 K 834 K 78 K 319 K 792 K 998 K 1.11 M 1.74 M 2.41 M 990 K 887 K 545 K - -

Retained Earnings

-104 M -109 M -98.3 M -98.4 M -92.3 M -93.3 M -100 M -103 M -107 M -108 M -114 M -111 M -76.5 M -77 M -88.5 M

Total Assets

72 M 60.3 M 66.1 M 70.7 M 78.7 M 58.9 M 55.3 M 51.1 M 45.2 M 50.3 M 40.9 M 54 M 55.5 M 44.5 M 12.5 M

Cash and Cash Equivalents

20.2 M 16.9 M 21.6 M 20.2 M 23.2 M 22.1 M 18.8 M 16.7 M 11.5 M 7.88 M 13.9 M 20.4 M 26.3 M 24.6 M 6.37 M

Book Value

34.6 M 26 M 34.6 M 31.5 M 36.8 M 33.3 M 27.2 M 21.9 M 14.5 M 12.1 M 3.32 M 3.99 M 33.9 M 28.3 M -20.8 M

Total Shareholders Equity

34.6 M 26 M 34.6 M 31.5 M 36.8 M 33.3 M 27.7 M 21.9 M 14.5 M 10.6 M 1.81 M 3.99 M 33.9 M 28.3 M -20.8 M

All numbers in USD currency

Quarterly Balance Sheet LifeVantage Corporation

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

9.31 M 9.81 M 10.4 M 10.9 M 11.5 M 11.8 M 11.9 M 12.1 M 12.5 M 11.6 M 11.9 M 12.3 M 12.6 M 13.2 M 13.9 M 14.6 M 15.3 M 16 M 16 M 15.4 M 13.2 M - - 288 K 680 K - - 2.43 M 2.92 M 3.41 M 3.41 M 4.46 M 4.95 M 5.44 M 5.44 M 6.42 M 6.92 M 7.41 M 7.41 M 1.04 M 5.02 M 8.53 M 8.53 M 22.8 M 23.9 M 25.1 M 25.1 M 41.2 M - - - - - - - - - - -

Total Liabilities

28.4 M 37.3 M 43.2 M 38.6 M 33.8 M 34.3 M 34.5 M 35.4 M 37.3 M 31.5 M 33.6 M 35.9 M 35.7 M 39.2 M 38.2 M 37.5 M 38.3 M 41.9 M 41.9 M 38.9 M 36.1 M 25.6 M 25.6 M 25.9 M 26.4 M 28.1 M 28.1 M 33.1 M 28.4 M 29.2 M 29.2 M 29.2 M 29 M 30.7 M 30.7 M 32 M 35.7 M 40.2 M 38.1 M 37.9 M 35 M 36.5 M 36.5 M 46.5 M 49.5 M 50 M 50 M 63.9 M 19.4 M 21.5 M 21.5 M 19.8 M 15.9 M 16.2 M 16.2 M 15.3 M 33.3 M 33.3 M 33.3 M

Deferred Revenue

700 K 700 K 1.3 M 1.4 M 1.1 M 900 K 700 K 900 K 1 M 800 K - - - - - - - 319 K - - - 792 K - - - 998 K - - - 1.11 M - - - 1.74 M - - - 2.41 M - - - 990 K - - - 887 K - - - 545 K - - - 210 K - - - - -

Retained Earnings

-103 M -104 M -104 M -106 M -109 M -109 M -108 M -107 M -104 M -98.3 M -99 M -99.6 M -98.2 M -98.4 M -96.2 M -95.6 M -92.5 M -92.3 M -92.3 M -93 M -92.9 M -93.3 M -93.3 M -96.8 M -99.1 M -100 M -100 M -102 M -102 M -103 M -103 M -106 M -106 M -107 M -107 M -107 M -107 M -109 M -108 M -111 M -113 M -114 M -114 M -112 M -109 M -111 M -111 M -113 M -76.1 M -76.5 M -76.5 M -72.8 M -72.8 M -77 M -77 M -76.6 M -84.7 M -88.5 M -88.5 M

Total Assets

61.6 M 72 M 77.2 M 68.5 M 61.5 M 60.3 M 61.3 M 62.7 M 66.6 M 66.1 M 67.1 M 67.8 M 67.6 M 70.7 M 72.2 M 72.2 M 75.6 M 78.7 M 78.7 M 74.4 M 70.2 M 58.9 M 58.9 M 55 M 56 M 55.3 M 55.3 M 54.1 M 51.9 M 51.1 M 51.1 M 45.7 M 44.8 M 45.2 M 45.2 M 46.5 M 49.8 M 50.9 M 50.3 M 44.9 M 39.6 M 39.8 M 39.8 M 51.1 M 56.7 M 54 M 54 M 63.4 M 54.5 M 55.5 M 55.5 M 54.8 M 50 M 44.5 M 44.5 M 24.7 M 17.1 M 12.5 M 12.5 M

Cash and Cash Equivalents

13.1 M 20.2 M 22.5 M 21.6 M 14.6 M 16.9 M 17.4 M 17.3 M 18.4 M 21.6 M 19.5 M 17.4 M 17.6 M 20.2 M 17.8 M 20.2 M 19.9 M 23.2 M 23.2 M 19.7 M 18 M 22.1 M 18 M 14.5 M 13 M 18.8 M 13 M 19 M 17.1 M 16.7 M 16.7 M 12.8 M 12.3 M 12.8 M 12.3 M 9.2 M 10.2 M 11.7 M 10.2 M 15.8 M 13.7 M 15.8 M 13.7 M 18.6 M 22.1 M 18.6 M 22.1 M 34.5 M 28 M 34.5 M 28 M 28.5 M 25.2 M 28.5 M 25.2 M 13.5 M 9.44 M 13.5 M 9.44 M

Book Value

33.2 M 34.6 M 34 M 29.9 M 27.7 M 26 M 26.8 M 27.3 M 29.3 M 34.6 M 33.4 M 31.9 M 31.9 M 31.5 M 34 M 34.8 M 37.3 M 36.8 M 36.8 M 35.5 M 34.1 M 33.3 M 33.3 M 29.1 M 29.6 M 27.2 M 27.2 M 21 M 23.5 M 21.9 M 21.9 M 16.5 M 15.8 M 14.5 M 14.5 M 14.5 M 14.1 M 10.6 M 12.1 M 7.01 M 4.58 M 3.32 M 3.32 M 4.55 M 7.2 M 3.99 M 3.99 M -548 K 35.1 M 33.9 M 33.9 M 35 M 34.1 M 28.3 M 28.3 M 9.33 M -16.2 M -20.8 M -20.8 M

Total Shareholders Equity

33.2 M 34.6 M 34 M 29.9 M 27.7 M 26 M 26.8 M 27.3 M 29.3 M 34.6 M 33.4 M 31.9 M 31.9 M 31.5 M 34 M 34.8 M 37.3 M 36.8 M 37.3 M 35.5 M 35.5 M 35.5 M 34.1 M 29.1 M 29.1 M 29.1 M 29.6 M 21 M 23.5 M 21 M 23.5 M 16.5 M 15.8 M 14.5 M 14.5 M 14.5 M 14.1 M 10.6 M 12.1 M 7.01 M 4.58 M 1.81 M 3.32 M 4.55 M 7.2 M 2.33 M 3.99 M -548 K 35.1 M 33.9 M 33.9 M 35 M 34.1 M 28.3 M 28.3 M 9.33 M -16.2 M -20.8 M -20.8 M

All numbers in USD currency

Balance Sheet is a fundamental financial report of LifeVantage Corporation, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Household products

Issuer Price % 24h Market Cap Country
Natura &Co Holding S.A. Natura &Co Holding S.A.
NTCO
- - $ 9.02 B -
The Clorox Company The Clorox Company
CLX
$ 100.83 0.02 % $ 12.5 B usaUSA
Colgate-Palmolive Company Colgate-Palmolive Company
CL
$ 79.02 -0.62 % $ 64.7 B usaUSA
Dogness (International) Corporation Dogness (International) Corporation
DOGZ
$ 10.6 1.73 % $ 357 M chinaChina
Coty Coty
COTY
$ 3.08 -1.91 % $ 2.68 B usaUSA
Acme United Corporation Acme United Corporation
ACU
$ 40.31 -0.15 % $ 149 M usaUSA
The Estée Lauder Companies The Estée Lauder Companies
EL
$ 104.72 -1.06 % $ 37.7 B usaUSA
e.l.f. Beauty e.l.f. Beauty
ELF
$ 76.04 -0.99 % $ 4.16 B usaUSA
Kimberly-Clark Corporation Kimberly-Clark Corporation
KMB
$ 100.89 -0.67 % $ 33.9 B usaUSA
Church & Dwight Co. Church & Dwight Co.
CHD
$ 83.85 -0.7 % $ 20.5 B usaUSA
Newell Brands Newell Brands
NWL
$ 3.72 -1.59 % $ 1.55 B usaUSA
Helen of Troy Limited Helen of Troy Limited
HELE
$ 21.25 -0.09 % $ 489 M bermudaBermuda
Hims & Hers Health Hims & Hers Health
HIMS
$ 32.47 -1.73 % $ 7.01 B usaUSA
Edgewell Personal Care Company Edgewell Personal Care Company
EPC
$ 17.05 -0.53 % $ 847 M usaUSA
Nu Skin Enterprises Nu Skin Enterprises
NUS
$ 9.62 -0.93 % $ 478 M usaUSA
The Procter & Gamble Company The Procter & Gamble Company
PG
$ 143.31 -0.51 % $ 337 B usaUSA
Inter Parfums Inter Parfums
IPAR
$ 84.83 0.22 % $ 2.71 B usaUSA
Nature's Sunshine Products Nature's Sunshine Products
NATR
$ 21.58 0.14 % $ 411 M usaUSA
United-Guardian United-Guardian
UG
$ 6.16 0.16 % $ 28.3 M usaUSA
Unilever PLC Unilever PLC
UL
$ 65.4 -0.34 % $ 132 B britainBritain
Mannatech, Incorporated Mannatech, Incorporated
MTEX
$ 8.25 3.77 % $ 15.4 M usaUSA
Revlon Revlon
REV
- -4.41 % $ 212 M usaUSA
Spectrum Brands Holdings Spectrum Brands Holdings
SPB
$ 59.08 -0.62 % $ 1.52 B usaUSA
USANA Health Sciences USANA Health Sciences
USNA
$ 19.63 -1.31 % $ 378 M usaUSA